Serge Lebecque
14Patents
3h-index
27Co-inventors
60Inventor score
Filing activity: Sep 17, 1984 → Sep 20, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6277959A | Isolated mammalian membrane protein genes; related reagents | Chemistry; Metallurgy | 23 | Expired |
| US4740371A | Treatment of allergy | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6756478B2 | Isolated mammalian membrane protein genes; related reagents | Chemistry; Metallurgy | 9 | Expired |
| US6933369B2 | Mammalian proteinases; oxidoreductases; related reagents | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6361939B1 | Isolated mammalian dendritic cell genes; related reagents | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6812004B1 | Mammalian dendritic cell chemokine reagents | Chemistry; Metallurgy | 0 | Expired |
| US11384081B2 | Benzoimidazole derivatives as anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US6878528B1 | Polynucleotides encoding a mammalian Langerhans cell antigen | Chemistry; Metallurgy | 0 | Expired |
| US7034137B2 | Isolated mammalian membrane protein genes; related reagents | Chemistry; Metallurgy | 0 | Expired |
| US7122380B1 | Pharmaceutical compositions containing antigen-antibody complexes and uses therefor | Human Necessities | 0 | Expired |
| US7691373B2 | Isolated mammalian membrane proteins; related agents | Chemistry; Metallurgy | 0 | Active |
| US7354705B2 | Methods for cancer prognosis and diagnosis | Physics | 0 | Expired |
| US9683986B2 | Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interaction | Physics | 0 | Active |
| US7179467B2 | DCMP2 polypeptide | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.